Overview of the Global Immuno-Oncology Assay Market: Key Statistics and Trends:
According to the latest report by MarkNtel Advisors, titled “Global Immuno-Oncology Assay Market By Product & Services (Reagents and Antibodies, Testing Kits, Instruments, Consumables & Accessories, Software), By Assay Type (Checkpoint Inhibitor Assays, Cytokine Profiling Assays, Protein Biomarker Assays, Genomic Sequencing and Mutational Analysis, Immune Profiling Assays, Tumour Biomarker Assays, Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)), By Technology (Polymerase Chain Reaction, Immunoassay, Next-generation Sequencing, In-situ Hybridization, Flow Cytometry, Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.)), By Indication, (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Others (Bladder Cancer, Melanoma, etc.)), By Application (Clinical Assay, Research & Development), By End User (Hospitals, Cancer Research Centers, Specialty Cancer Clinics, Clinical Laboratories, Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.)), The Global Immuno-Oncology Assay Market size is valued at around USD 5.77 billion in 2024 and is estimated to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28. The report provides a thorough analysis of the market, covering competitor dynamics, regional insights, and a detailed breakdown of industry segments.
Global Immuno-Oncology Assay Market Growth and Scope:
Base Year: 2022
Forecast Period: 2023-28
Historical Data: 2018-21
CAGR (2023-2028): 12.5%
Request Free Sample Report (Exclusive Offer on this report): https://www.marknteladvisors.com/query/request-sample/immuno-oncology-assay-market.html
In case you missed it, we are currently revising our reports. Click on the “request sample report” button to get the latest research data with forecast for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Global Immuno-Oncology Assay Market Trend:
Increasing Adoption of Liquid Biopsy Techniques for Early Cancer Detection and Monitoring– The increasing adoption of liquid biopsy techniques for early cancer detection and monitoring in recent years represents a transformative shift in oncology. The growing adoption of liquid biopsies has gained traction through their potential to revolutionize cancer management by facilitating earlier interventions, more personalized treatment plans, and reduced patient discomfort.
Additionally, immunoassays have been largely preferred by clinical laboratories to detect cancer biomarkers using samples that are typically tagged with fluorescent, chemiluminescent, or oligo-coupled tags. It has been majorly attributed to the accuracy provided by the immunoassay techniques, which has improved its adoption along with liquid biopsy testing methods. Hence, the increasing adoption of liquid biopsy techniques has significantly supported the growth of immuno-oncology assay services demand in recent years.
A Comprehensive Analysis of Leading Companies of Immuno-Oncology Assay Market by MarkNtel Advisors:
- Agilent Technologies Inc.
- Aviva Systems Biology Corporation
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc.
- Illumina Inc.
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- NanoString Technologies, Inc.
- BioGenex
- Abbott Laboratories, Inc.
- Asuragen Inc.
- Meso Scale Assay, LLC
- Merck Millipore
- Enzo Biochem Inc.
- Others
Key Immuno-Oncology Assay Market Segmentation:
Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html
-By Product & Services
- Reagents and Antibodies
- Testing Kits
- Instruments
- Consumables & Accessories
- Software
Among them, reagents and antibodies are pivotal components that play a significant role in cancer diagnosis and monitoring, owing to which, they have been dominating the Global Immuno-Oncology Assay Market over the historical years.
-By Indication
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Ovarian Cancer
- Others (Bladder Cancer, Melanoma, etc.)
Among them all, the Prostate cancer segment commands the largest share in the market. This is primarily due to the increasing prevalence of prostate cancer worldwide.
-By Assay Type
- Checkpoint Inhibitor Assays- Market Size & Forecast 2018-2028F, USD Million
- Cytokine Profiling Assays- Market Size & Forecast 2018-2028F, USD Million
- Protein Biomarker Assays- Market Size & Forecast 2018-2028F, USD Million
- Genomic Sequencing and Mutational Analysis- Market Size & Forecast 2018-2028F, USD Million
- Immune Profiling Assays- Market Size & Forecast 2018-2028F, USD Million
- Tumour Biomarker Assays- Market Size & Forecast 2018-2028F, USD Million
- Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)- Market Size & Forecast 2018-2028F, USD Million
-By Technology
- Polymerase Chain Reaction- Market Size & Forecast 2018-2028F, USD Million
- Immunoassay- Market Size & Forecast 2018-2028F, USD Million
- Next-generation Sequencing- Market Size & Forecast 2018-2028F, USD Million
- In-situ Hybridization- Market Size & Forecast 2018-2028F, USD Million
- Flow Cytometry- Market Size & Forecast 2018-2028F, USD Million
- Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.) – Market Size & Forecast 2018-2028F, USD Million
-By Application
- Clinical Assay- Market Size & Forecast 2018-2028F, USD Million
- Research & Development- Market Size & Forecast 2018-2028F, USD Million
-By End User
- Hospitals- Market Size & Forecast 2018-2028F, USD Million
- Cancer Research Centers- Market Size & Forecast 2018-2028F, USD Million
- Specialty Cancer Clinics- Market Size & Forecast 2018-2028F, USD Million
- Clinical Laboratories- Market Size & Forecast 2018-2028F, USD Million
- Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.) – Market Size & Forecast 2018-2028F, USD Million
Geographical Analysis
-By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
North America’s preeminence in the global Immuno-Oncology Assay Market is underpinned by a multifaceted landscape shaped by various factors.
Key Reports Highlights:
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”
Key Advantages of the Report by MarkNtel Advisors:
- Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key sub segments, benefiting both market leaders and new entrants.
- Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.
- Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.
Note: If you need additional information not included in the report, we can customize it to suit your requirements.
Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/immuno-oncology-assay-market.html
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
More Research Studies:
- The Almond Butter Market is valued at USD 1.03 billion in 2024 and is expected to reach USD 1.56 billion by 2030, growing at a CAGR of 7.19%
- Astrology App Market size was valued at around USD 3 billion in 2024 & is projected to reach USD 9 billion by 2030 along with a CAGR of 20%.
- The Data Integration Market is projected to grow from USD 14.23 billion in 2024 to USD 30.87 billion by 2030, with a CAGR of 13.78% during 2025-2030.
- The Global Graph Database Market, valued at USD 3.12 billion in 2024, is projected to grow at a 23.56% CAGR from 2025-30, driven by AI tools and low-latency query processing.
Media Contact:
Company Name: MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com/
Phone: +1 628 895 8081, +91 70 4278433
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, India
